Source: Breathe, 15 (3) 216; 10.1183/20734735.0205-2019
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Diego Severiche-Bueno, Daniela Parra-Tanoux, Luis F. Reyes, Grant W. Waterer. Hot topics and current controversies in community-acquired pneumonia. Breathe, 15 (3) 216; 10.1183/20734735.0205-2019

Member's Comments

No comment yet.

Related content which might interest you: Update on therapeutic strategies in community-acquired pneumonia    Source: International Congress 2017 – PG17 Infectious disease challenges in community-acquired pneumonia and tuberculosis: improving your clinical practice Year: 2017 Severe community-acquired pneumonia in China: epidemiology and clinical practice Source: International Congress 2019 – Chinese programme 2019: Part II Year: 2019 Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia Source: ERJ Open Res, 4 (2) 00028-2018; 10.1183/23120541.00028-2018 Year: 2018 Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia Source: Guideline 2018 Year: 2019 Evaluation of guidelines for community-acquired pneumonia: a story of confounders, surprises and challenges Source: Eur Respir J 2008; 32: 823-825 Year: 2008 Update on community-acquired pneumonia Source: International Congress 2017 – ME5 Update on community-acquired pneumonia Year: 2017 Management of community-acquired pneumonia: new evidence-based algorithms. Source: Virtual Congress 2021 – Emerging data for the management of respiratory tract infections Year: 2021 Challenges in the management of hospital-acquired pneumonia including ventilator-associated pneumonia Source: ERS Course 2018 - Respiratory Infections Year: 2018 The impact of 2016 guideline on clinical practice for the management of hospital-acquired and ventilator-associated pneumonia in Taiwan Source: International Congress 2018 – Difficult-to-treat respiratory infections Year: 2018 Factors associated with unknown aetiology in patients with community-acquired pneumonia Source: Eur Respir J 2002; 20: 1254-1262 Year: 2002 International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia Source: Eur Respir J, 50 (3) 1700582; 10.1183/13993003.00582-2017 Year: 2017 International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia Source: Guideline 2017 Year: 2017 Epidemiology of community-acquired pneumonia and nosocomial pneumonia Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections Year: 2006 Aspiration risks factors, microbiology and empiric antibiotics for patients hospitalized with community-acquired pneumonia Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice Year: 2020 Biomarkers and clinical stability in community-acquired pneumonia Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009 The assessment of physicians' knowledge of community-acquired pneumonia basics: KNOCAP study Source: International Congress 2019 – Medical education Year: 2019 Community-acquired pneumonia in pediatric patients: New diagnostic priorities Source: Annual Congress 2012 - Asthma management Year: 2012 Challenges in understanding host genetics and severity of community-acquired pneumonia Source: ERJ Open Res, 7 (1) 00745-2020; 10.1183/23120541.00745-2020 Year: 2021 Adherence to guidelines' empirical antibiotic recommendations and community-acquired pneumonia outcome Source: Eur Respir J 2008; 32: 892-901 Year: 2008 Validation of treatment adequacy of current guidelines for hospital-acquired pneumonia Source: Annual Congress 2003 - Epidemiology, therapy and outcome of infections in the ICU Year: 2003